• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Nasdaq Gains Over 50 Points; US Producer Prices Increase In March

    4/11/24 9:41:48 AM ET
    $APVO
    $CLRO
    $ELYM
    $ENLV
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Telecommunications Equipment
    Utilities
    Get the next $APVO alert in real time by email

    U.S. stocks traded mostly higher this morning, following the release of PPI data.

    Following the market opening Thursday, the Dow traded up 0.03% to 38,472.80 while the NASDAQ rose 0.40% to 16,234.94. The S&P 500 also rose, gaining, 0.17% to 5,169.21.

    Check This Out: How To Earn $500 A Month From Citigroup Stock Ahead Of Q1 Earnings Report

     

    Leading and Lagging Sectors

     

    Real estate shares rose by 0.6% on Thursday.

    In trading on Thursday, financial shares fell by 0.1%.

     

    Top Headline

     

    Producer prices in the U.S. rose 0.2% month-over-month in March compared to a 0.6% gain in February. However, analysts were expecting a gain of 0.3%.

     

    Equities Trading UP

     

    Rallybio Corporation (NASDAQ:RLYB) shares shot up 95% to $3.1793 after the company announced a collaboration with Johnson & Johnson to advance therapeutics for pregnant individuals at risk of FNAIT.

    Shares of Eliem Therapeutics, Inc. (NASDAQ:ELYM) got a boost, surging 60% to $4.2747. The company announced that it entered into a definitive acquisition agreement to acquire Tenet and it also entered into a securities purchase agreement for a $120 million private placement.

    Rent the Runway, Inc. (NASDAQ:RENT) shares were also up, gaining 46% to $10.80 after the company reported mixed fourth-quarter financial results and issued guidance.

     

    Equities Trading DOWN

     

    Aptevo Therapeutics Inc. (NASDAQ:APVO) shares dropped 57% to $1.0398 after the company priced its $4.6 million public offering.

    Shares of Enlivex Therapeutics Ltd. (NASDAQ:ENLV) were down 49% to $2.02. The company announced topline results of its Phase II trial evaluating Allocetra in sepsis.

    ClearOne, Inc. (NASDAQ:CLRO) was down, falling 10% to $0.98.

    Also Check This Out: Top 3 Financial Stocks That Are Ticking Portfolio Bombs

     

    Commodities

     

    In commodity news, oil traded down 0.4% to $85.86 while gold traded up 0.4% at $2,358.80.

    Silver traded up 0.4% to $28.15 on Wednesday, while copper fell 0.4% to $4.2660.

     

    Euro zone

     

    European shares were mixed today. The eurozone’s STOXX 600 rose 0.1%, London’s FTSE 100 fell 0.2% while Spain’s IBEX 35 Index fell 0.7% The German DAX fell 0.2% French CAC 40 rose 0.2% while Italy’s FTSE MIB Index fell 0.4%.

    The European Central Bank kept interest rates unchanged for a fifth straight time during its April meeting.

     

    Asia Pacific Markets

     

    Asian markets closed mixed on Thursday, with Japan’s Nikkei 225 falling 0.35%, Hong Kong’s Hang Seng Index dropping 0.26%, China’s Shanghai Composite gaining 0.23% and India’s S&P BSE Sensex gaining 0.47%.

    China's consumer prices rose 0.1% year-over-year in March, while producer prices fell by 2.8% year-over-year in March.

     

    Economics

     

    Producer prices in the U.S. rose 0.2% month-over-month in March compared to a 0.6% gain in February. However, analysts were expecting a gain of 0.3%.

    U.S. initial jobless claims declined by 11,000 to 211,000 in the week ending April 6, compared to market estimates of 215,000.

    Now Read This: Citigroup Likely To Report Lower Q1 Earnings; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts

    Get the next $APVO alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $APVO
    $CLRO
    $ELYM
    $ENLV

    CompanyDatePrice TargetRatingAnalyst
    Rallybio Corporation
    $RLYB
    4/9/2025Buy → Neutral
    H.C. Wainwright
    Rallybio Corporation
    $RLYB
    5/15/2024Overweight → Neutral
    JP Morgan
    Rallybio Corporation
    $RLYB
    2/7/2024$7.00 → $1.50Buy → Hold
    Jefferies
    Rent the Runway Inc.
    $RENT
    1/17/2024Overweight → Neutral
    Piper Sandler
    Rent the Runway Inc.
    $RENT
    1/16/2024Overweight → Equal Weight
    Wells Fargo
    Rallybio Corporation
    $RLYB
    4/17/2023$18.00Buy
    H.C. Wainwright
    Rallybio Corporation
    $RLYB
    4/10/2023$17.00Outperform
    Wedbush
    Rent the Runway Inc.
    $RENT
    12/15/2022Peer Perform
    Wolfe Research
    More analyst ratings

    $APVO
    $CLRO
    $ELYM
    $ENLV
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13G/A filed by Rent the Runway Inc.

    SCHEDULE 13G/A - Rent the Runway, Inc. (0001468327) (Subject)

    2/11/26 4:29:22 PM ET
    $RENT
    Other Specialty Stores
    Consumer Discretionary

    SEC Form 6-K filed by Enlivex Therapeutics Ltd.

    6-K - Enlivex Therapeutics Ltd. (0001596812) (Filer)

    2/10/26 8:02:52 AM ET
    $ENLV
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 6-K filed by Enlivex Therapeutics Ltd.

    6-K - Enlivex Therapeutics Ltd. (0001596812) (Filer)

    2/5/26 7:50:49 AM ET
    $ENLV
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $APVO
    $CLRO
    $ELYM
    $ENLV
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3 filed by new insider Boehnke Eric

    3 - CLEARONE INC (0000840715) (Issuer)

    12/30/25 6:21:53 PM ET
    $CLRO
    Telecommunications Equipment
    Utilities

    Director Rosensweig Daniel was granted 16,759 shares, increasing direct ownership by 338% to 21,715 units (SEC Form 4)

    4 - Rent the Runway, Inc. (0001468327) (Issuer)

    12/18/25 4:21:04 PM ET
    $RENT
    Other Specialty Stores
    Consumer Discretionary

    SEC Form 4 filed by Chief Merchant Officer Tam Sarah K

    4 - Rent the Runway, Inc. (0001468327) (Issuer)

    12/18/25 4:19:52 PM ET
    $RENT
    Other Specialty Stores
    Consumer Discretionary

    $APVO
    $CLRO
    $ELYM
    $ENLV
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Rallybio downgraded by H.C. Wainwright

    H.C. Wainwright downgraded Rallybio from Buy to Neutral

    4/9/25 8:36:28 AM ET
    $RLYB
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Rallybio downgraded by JP Morgan

    JP Morgan downgraded Rallybio from Overweight to Neutral

    5/15/24 7:39:44 AM ET
    $RLYB
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Rallybio downgraded by Jefferies with a new price target

    Jefferies downgraded Rallybio from Buy to Hold and set a new price target of $1.50 from $7.00 previously

    2/7/24 6:42:56 AM ET
    $RLYB
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $APVO
    $CLRO
    $ELYM
    $ENLV
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Enlivex Treasury Portfolio Update: New Listing of the RAIN Token on Kraken, the Second-Largest U.S. Cryptocurrency Exchange

    Additional exchange listing expected to increase token access and contribute to expanded secondary market liquidity for RAIN Nes-Ziona, Israel, Feb. 10, 2026 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (NASDAQ:ENLV, "Enlivex" or "the Company")) today reported that its primary treasury asset, the RAIN token, has been listed on the Kraken cryptocurrency exchange effective February 9, 2026, further expanding access to the token across an additional digital asset trading platform. Kraken is the second-largest U.S.-based cryptocurrency exchange, and was founded in 2011. The exchange serves 5.7 million users across numerous jurisdictions and supports a broad range of digital assets through

    2/10/26 8:00:00 AM ET
    $ENLV
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Rallybio Announces Reverse Stock Split of Common Stock

    Rallybio Corporation (NASDAQ:RLYB) will effect a one-for-eight reverse stock split of its issued and outstanding common stock. Stockholders of Rallybio approved an amendment to Rallybio's Amended and Restated Certificate of Incorporation (the "Amendment") to effect the reverse stock split at a Special Meeting of Stockholders held on January 26, 2026. The reverse stock split is intended to give Rallybio greater flexibility in considering and planning for future potential business needs and to increase the per share trading price of the Rallybio common stock to enable Rallybio to satisfy the minimum price requirement for continued listing on the Nasdaq Capital Market. Pursuant to the Amendmen

    2/3/26 4:05:00 PM ET
    $RLYB
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Enlivex Treasury Portfolio Update: Listing of the RAIN Token on WhiteBIT, a Leading Cryptocurrency Exchange

    Listing expected to expand market access and secondary liquidity for Enlivex's primary digital treasury asset Nes-Ziona, Israel, Jan. 26, 2026 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (NASDAQ:ENLV, "Enlivex" or "the Company")) today reported that its primary treasury asset, the RAIN token, has been listed on the WhiteBIT cryptocurrency exchange effective January 21, 2026, expanding access to the token across a major global digital asset trading platform. WhiteBIT is the largest European cryptocurrency exchange by traffic. Founded in 2018, the platform is part of W Group, which serves more than 35 million customers globally. The commencement of RAIN trading on WhiteBIT is expected t

    1/26/26 8:00:00 AM ET
    $ENLV
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $APVO
    $CLRO
    $ELYM
    $ENLV
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Grant Grady Iii bought $20,134 worth of shares (13,513 units at $1.49), increasing direct ownership by 1,351,300% to 13,514 units (SEC Form 4)

    4 - Aptevo Therapeutics Inc. (0001671584) (Issuer)

    11/12/25 4:33:00 PM ET
    $APVO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Large owner Bagley Edward D bought $1,000,000 worth of shares (2,000,000 units at $0.50), increasing direct ownership by 19% to 12,590,528 units (SEC Form 4)

    4 - CLEARONE INC (0000840715) (Issuer)

    2/28/25 4:05:40 PM ET
    $CLRO
    Telecommunications Equipment
    Utilities

    Director Ra Capital Management, L.P. was granted 5,259,872 shares and bought $49,952,817 worth of shares (13,008,546 units at $3.84) (SEC Form 4)

    4 - Eliem Therapeutics, Inc. (0001768446) (Issuer)

    7/1/24 9:29:04 PM ET
    $ELYM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $APVO
    $CLRO
    $ELYM
    $ENLV
    Leadership Updates

    Live Leadership Updates

    View All

    Enlivex Appoints former Italy Prime Minister Matteo Renzi to Board of Directors

    Enlivex Announced today $212,000,000 private placement to initiate world's first prediction markets digital asset treasury strategy, via RAIN token accumulation NESS ZIONA, Israel, Nov. 24, 2025 /PRNewswire/ -- Enlivex Therapeutics Ltd. (NASDAQ:ENLV) today announced the appointment of Mr. Matteo Renzi, former Prime Minister of Italy, to the board of directors at Enlivex, effective November 24th. 2025. Enlivex Therapeutics Ltd., a clinical-stage macrophage reprogramming immunotherapy company, today announced that it has entered into a securities purchase agreement for a private investment in public equity (PIPE) for the purchase and sale of 212,000,000 ordinary shares (or ordinary share equi

    11/24/25 10:00:00 AM ET
    $ENLV
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Enlivex Announces $212,000,000 Private Placement to Initiate World's First Prediction Markets Digital Asset Treasury Strategy, via RAIN token Accumulation, and the Appointment of Matteo Renzi, Former Prime Minister of Italy, to its Board

    - Upon the closing of the private placement, Enlivex will adopt the world's first RAIN prediction markets token digital asset treasury strategy, via RAIN token accumulation. - RAIN is a fully decentralized predictions and options protocol that redefines predictive market ecosystems and provides a powerful platform for on-chain market creation - built for transparency, automation, and community participation. - Mr. Matteo Renzi, former Prime Minister of Italy, will be appointed to the Enlivex Board of Directors following closing of the private placement. - Enlivex to continue clinical development of Allocetra™, a potentially game-changing knee osteoarthritis therapeutic, a growing market w

    11/24/25 7:55:00 AM ET
    $ENLV
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Eliem Therapeutics Reports Second Quarter Financial Results

    Eliem completed the acquisition of Tenet Medicines and concurrent $120 million private placement Eliem to host an Investor Day later in the year to provide an overview of budoprutug (previously referred to as TNT119), pipeline expansion strategy and anticipated milestones Cash and cash equivalents of approximately $220 million expected to fund operations into 2027, to enable the potential attainment of key clinical and development milestones for budoprutug SEATTLE and CAMBRIDGE, United Kingdom, Aug. 14, 2024 (GLOBE NEWSWIRE) --  Eliem Therapeutics, Inc. (NASDAQ:ELYM) ("Eliem" or the "Company"), today reported financial results for the quarter ended June 30, 2024 and provided a business

    8/14/24 6:05:00 AM ET
    $ELYM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $APVO
    $CLRO
    $ELYM
    $ENLV
    Financials

    Live finance-specific insights

    View All

    Rent the Runway, Inc. Announces Third Quarter 2025 Results

    Continued Growth of the Business with Q3 Ending Active Subscribers +12.4% YoY; Revenue up 15.4% YOY Closed Transformative Recapitalization Plan, Strengthening the Balance Sheet and Injecting Capital into the Business Expanded our Community-driven Organic Growth Strategy to Drive Brand Awareness and Acquisition NEW YORK, Dec. 12, 2025 (GLOBE NEWSWIRE) -- Rent the Runway, Inc. ("Rent the Runway" or "RTR") (NASDAQ:RENT), the company transforming the way women get dressed, today reported financial results for the fiscal quarter ended October 31, 2025. Rent the Runway is delivering on its multi-year transformation plan, achieving substantial growth on the heels of its largest inventory inve

    12/12/25 8:01:00 AM ET
    $RENT
    Other Specialty Stores
    Consumer Discretionary

    Enlivex Management to Host Fireside Chat on December 11 to Discuss RAIN Token Strategy and Allocetra Clinical Development

    Nes-Ziona, Israel, Dec. 04, 2025 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (NASDAQ:ENLV, "Enlivex" or "the Company")), today announced that it will host a virtual fireside chat on Thursday, December 11, 2025 at 11:00 am ET. Shai Novik, Executive Chairman of Enlivex, will provide an update on the Company's plans following its recently closed $212,000,000 private placement. Mr. Novik will discuss the launch of Enlivex's digital asset treasury strategy built around RAIN token accumulation as well as the Company's plans to continue to advance the clinical development of AllocetraTM. Virtual Fireside Chat Details Date: December 11, 2025Time: 11:00 am ETRegistration Link:https://shorturl

    12/4/25 8:00:00 AM ET
    $ENLV
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Rent the Runway to Report Third Quarter 2025 Results on December 12, 2025

    NEW YORK, Nov. 21, 2025 (GLOBE NEWSWIRE) -- Rent the Runway, Inc. ("Rent the Runway") (NASDAQ:RENT) announced today that it expects to release its third quarter 2025 financial results for the quarter ended October 31, 2025 on Friday, December 12, 2025, before market open. Rent the Runway will host a conference call and live webcast with the investment community at 8:30 a.m. Eastern Time that same day to discuss its results and to provide a business update. The financial results and live webcast, including presentation materials, will be accessible through the Investor Relations section of Rent the Runway's website at https://investors.renttherunway.com/ under the "Events" section. To acce

    11/21/25 4:01:00 PM ET
    $RENT
    Other Specialty Stores
    Consumer Discretionary

    $APVO
    $CLRO
    $ELYM
    $ENLV
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Rent the Runway Inc.

    SC 13G/A - Rent the Runway, Inc. (0001468327) (Subject)

    11/14/24 5:08:56 PM ET
    $RENT
    Other Specialty Stores
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by Aptevo Therapeutics Inc.

    SC 13G/A - Aptevo Therapeutics Inc. (0001671584) (Subject)

    11/14/24 3:45:38 PM ET
    $APVO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form SC 13G filed by Enlivex Therapeutics Ltd.

    SC 13G - Enlivex Therapeutics Ltd. (0001596812) (Subject)

    11/14/24 3:29:35 PM ET
    $ENLV
    Biotechnology: Pharmaceutical Preparations
    Health Care